WSU Honors WSU Graduate Alumni Hohenschuh, Perryman

PULLMAN, Wash. — Paul F. Hohenschuh of Burlingame, Calif., and Dr. Lance Perryman of Cary, N.C., received Graduate Alumni Achievement Awards at Washington State University. The pair was honored at an April 24 luncheon sponsored by the WSU Graduate School and the Graduate and Professional Students Association.

The awards, created last year, recognize alumni who have earned graduate or professional degrees at WSU “for outstanding achievement and contributions to their community, profession and/or society.”

Hohenschuh completed a bachelor’s degree (1964) and a master’s degree (1969) in chemical engineering. After finishing his master’s, he became plant production supervisor with Monsanto in Texas City, Texas. He eventually served on the executive team that evaluated venture capital investments in the emerging biotechnology industry. He played an instrumental role in developing Genentech, one of the world’s leading biotechnology/pharmaceutical companies. Last year, he retired as vice president of manufacturing. Now he is involved in the Menttium Program — a cross-industry mentoring program for high-achieving women professionals. He also has volunteered in community fund-raising projects and organizations.

Perryman is professor and chair of the department of veterinary microbiology, pathology and parasitology in the College of Veterinary Medicine at North Carolina State University. He received both his doctor of veterinary medicine degree (1970) and a doctorate in veterinary science (1975) from WSU.

Between 1975-94, he was a WSU faculty member in the veterinary microbiology and pathology department. He served on dozens of departmental and university committees.

Perryman is president of the Association of Veterinary Pathology Chairpersons and past president of both the American College of Veterinary Pathologists and the American Association of Immunologists.

He is the author or co-author of more than 150 refereed scientific papers and has helped generate roughly $8.5 million in extramural research funding that has been used to enhance society’s understanding of important human diseases.